Magnetism offers extremely promising perspectives in biology, particularly in mechanobiology and for various biomedical ...

The Brain Prize 2025 went to neuro-oncologists Michelle Monje and Frank Winkler for pioneering the field of cancer n.

TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from ...

Haigis and Sabatini are co-senior authors of the study. Gliomas derive from glia, cells that perform essential functions in sculpting and maintaining neural circuits. Scientists already knew that ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the Glioma pipeline drug ...

while a 2017 study published in Nature highlighted the potential of oncolytic viruses in overcoming immune evasion by glioma cells. Arthur Portnoy, co-founder of Biotherapy International ...

The study sheds light on how tumor cells ... High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, incidence of recurrence ...

Further, T cells treated with KROS 101 showed cytotoxicity against glioblastoma cell lines and glioma cancer cells, which study authors, Admasu, et. al., concluded KROS 101 demonstrated potent ...